Transcription units Ela and Elb of the human adenoviruses encode at least
five proteins and all of the functions needed for the oncogenic
transformation of primary rodent cells to cell lines that are immortalized
and have altered morphology and growth properties, both in vitro and in
vivo. This transformation process will be characterized for its dependence
on the level at which E1 products are expressed, the effects of certain E1
products upon the expression of others, the degree to which different El
products are required and at what threshold levels for each of several
different characteristics of transformed cells, and the effects of E1
proteins on selected aspects of cellular structure and gene expression.
These studies will help to elucidate the mechanisms involved in
transforming normal to neoplastic cells, and should suggest strategies for
controlling the growth of tumor cells.
Chimetric DNA molecules will be constructed in which the expression of
these E1 genes is controlled by regulatory sequences derived from other
genes so that expression will occur at a variety of levels and in some
cases can be modulated by factors in the medium. These molecules will be
introduced into rodent cells by co-transfection with selectable markers,
and the resulting colonies scored for levels of individual El gene
products, for effects on morphology, anchorage independent growth, and
saturation density, and for effects on host cell gene expression. The
variation of these parameters with the level of expression of adenovirus
gene will be noted. Transient overexpression of viral gene products will
be induced in an effort to amplify and thereby identify effects on host
cells that may be otherwise undetectable in established transformed cells.
To investigate the individual effects and interactions of the five
proteins, appropriate plasmids will be constructed that each express only
one or a few El proteins. The effect of each of these plasmids alone, or
in combination with other such plasmids, on the expression of other El
genes, on the initiation and maintenance of the transformed phenotype, and
on parameters of cell growth, structure, and gene expression will be
investigated. Similarly, individual domains within multifunctional
proteins will be identified by constructing and testing plasmids containing
appropriate mutations.
No Sub Projects information available for 7R01CA039636-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01CA039636-03
Patents
No Patents information available for 7R01CA039636-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01CA039636-03
Clinical Studies
No Clinical Studies information available for 7R01CA039636-03
News and More
Related News Releases
No news release information available for 7R01CA039636-03
History
No Historical information available for 7R01CA039636-03
Similar Projects
No Similar Projects information available for 7R01CA039636-03